| Home | Log In | Register | Our Services | My Account | Contact | Help |
Fracking sand (KENV)
hangon - 12 Oct 2012 14:37
Ooer...Let's hope the Oil industry needs this - and is prepared to pay well for it.
The good news is that sand doesn't have a shelf-life and you can always look at your investment, build sandcastles and so on....while waiting for the tide to come in.
New management team is off to a modestly good start, June 2012.
Bullshare
- 18 Nov 2016 10:22
- 2 of 3
Shares Investor Evenings showcase presentations from leading companies bringing them together in one room.
- Directors present their latest plans regarding development and growth
- An opportunity to talk directly to the companies and personally put forward your questions
- The chance to network with other attendees over drinks and canapés - private investors, wealth managers, fund managers and financial institutions
The evening exposes investors to companies across various sectors. Perfect for existing investors as well as those looking for new investment opportunities.
Tuesday 29th November 2016
Venue:Novotel Tower Bridge, London EC3N, 10 Pepys Street, London, EC3N 2NR
Event Timings:| 18.00 | Registration and coffee | |
| 18.30 | Presentations • Peter Secker, CEO - Bacanora Minerals (BCN) • Giles Clarke, Chairman - Kennedy Ventures (KENV) • Dr. George Morris, Chief Operations Officer - Valirx (VAL) + More to be announced | |
| 20.30 | Drinks reception and canapés | |
| 21.30 | Close |
 | Bacanora Minerals Ltd is an explorer and developer of industrial minerals in Mexico with a primary focus on Borates and Llithium. It was incorporated in Alberta, Canada in September 2008 and is listed on the TSX Venture Exchange (ticker = BCN). Although listed in Canada, we are proud to consider ourselves a Mexican Company. The word Bacanora refers to a Mexican agave liquor traditionally distilled in the hills of Sonora with much care and attention. Bacanora Minerals strives to replicate this tradition of skill and dedication to quality in its own operations.
|
 | Kennedy Ventures plc is an investing company listed on AIM, focused on principally, but not exclusively, in the resources sector. The Company has made a first investment in African Tantalum (Pty) Ltd, a Namibian based operation producing tantalite concentrate. In view of the attractive opportunities in tantalum, the Company is likely to initially focus on related projects located in Southern Africa. |
 | Valirx Plc is an oncology-focussed Biopharmaceutical Company, developing treatments and diagnostics. Technologies are selected by using rigorous clinical and commercial processes to address unmet market needs. Clinical lead product is VAL201, a peptide for prostate cancer with follow-on indications in ovarian and breast cancers and endometriosis. Product VAL401, is a small molecule reformulation for lung cancers. The Company’s proprietary technology platform, GeneICE, enables selective silencing of rebellious genes’ inappropriate activity. VAL101, the first GeneICE therapeutic, targets and reduces expression of Bcl-2, implicated in about half of cancers. GeneICE extension to neurology and inflammatory diseases will follow. A novel diagnostic, the Nav3 system, detects pre-cancerous, cancerous and metastatic cells in tissue samples even before a tumour forms; indicating potential malignant formation. |
hangon - 03 Jan 2017 15:52 - 3 of 3
"....AGM at 11.00am on Monday 16 January 2017, at Kennedy's offices, Lakeside, Fountain Lane, St Mellons, Cardiff, CF3 0FB....."
...was that enough Notice?
- Page:
- 1
| About MoneyAM | Ts and Cs | Privacy Policy | Investment Warning | Content Standards | Corporate Solutions | Advertise With Us | Site Map | © 2025 MoneyAM |
Follow us on Twitter